NVS Projected Dividend Yield
ADR (Sponsored)/Novartis AG Basel ( NYSE : NVS )Novartis AG is a Switzerland-based pharmaceutical company. Co. develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. Co. uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Co. are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars. 29 YEAR PERFORMANCE RESULTS |
NVS Dividend History Detail NVS Dividend News NVS Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2025 |
N/A |
Mar 12, 2025 |
Mar 12, 2025 |
Apr 25, 2025 |
3.9940 |
2025 Total: |
3.9940 |
||||
2024 |
N/A |
Mar 07, 2024 |
Mar 08, 2024 |
Apr 19, 2024 |
3.7395 |
2024 Total: |
3.7395 |
||||
2023 |
N/A |
Mar 09, 2023 |
Mar 10, 2023 |
Mar 20, 2023 |
2.2742 |
2023 Total: |
2.2742 |
||||
2022 |
N/A |
Mar 08, 2022 |
Mar 09, 2022 |
Mar 17, 2022 |
2.1614 |
2022 Total: |
2.1614 |
||||
2021 |
N/A |
Mar 04, 2021 |
Mar 05, 2021 |
Mar 15, 2021 |
2.0794 |
2021 Total: |
2.0794 |
||||
2020 |
N/A |
Mar 03, 2020 |
Mar 04, 2020 |
Mar 12, 2020 |
2.0068 |
2020 Total: |
2.0068 |